Innovent Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:1801 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Jul 24	SellHK$99,421,894	Capital Research and Management Company	Company	2,755,000	HK$36.09
03 May 24	SellHK$36,587,668	De-Chao Yu	Individual	906,250	HK$40.37
02 Feb 24	BuyHK$60,788,476	Capital Research and Management Company	Company	1,869,776	HK$32.51
12 Jan 24	BuyHK$51,892,586	Capital Research and Management Company	Company	1,292,500	HK$40.15
05 Jan 24	SellHK$133,714,368	Capital Research and Management Company	Company	3,456,000	HK$38.69
25 Oct 23	BuyHK$103,314,132	Capital Research and Management Company	Company	2,249,500	HK$45.93
17 Oct 23	SellHK$22,237,564	De-Chao Yu	Individual	502,961	HK$44.21
12 Oct 23	SellHK$143,016,662	Capital Research and Management Company	Company	3,324,500	HK$43.02
21 Sep 23	SellHK$877,219,533	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	23,185,276	HK$37.84
12 Sep 23	BuyHK$908,012,098	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	25,518,000	HK$35.58

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1801?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	10,614,500	0.652%
VC/PE Firms	89,475,350	5.49%
Individual Insiders	114,734,823	7.05%
General Public	647,557,421	39.8%
Institutions	766,031,476	47%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.7%.

Top Shareholders

Top 25 shareholders own 50.27% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.97%	Capital Research and Management Company	113,425,003	HK$4.6b	-0.65%	0.03%
6.77%	De-Chao Yu	110,253,778	HK$4.4b	0.92%	no data
5.49%	SDIC Innovation Investment Management Co., Ltd.	89,475,350	HK$3.6b	0%	32.88%
3.58%	The Vanguard Group, Inc.	58,320,770	HK$2.4b	0.79%	no data
3.4%	Eli Lilly Investment Consulting (Shanghai) Co., Ltd.	55,364,540	HK$2.2b	0%	49.29%
2.7%	GF Fund Management Co., Ltd.	43,973,655	HK$1.8b	0%	0.57%
2.66%	BlackRock, Inc.	43,298,993	HK$1.7b	0.34%	no data
1.85%	Fidelity International Ltd	30,137,962	HK$1.2b	-0.01%	0.07%
1.83%	Temasek Holdings (Private) Limited	29,766,000	HK$1.2b	-18.5%	0.15%
1.68%	E Fund Management Co., Ltd.	27,411,000	HK$1.1b	0%	0.22%
1.66%	Canada Pension Plan Investment Board	27,004,000	HK$1.1b	0%	0.09%
1.59%	Harvest Fund Management Co. Ltd.	25,912,788	HK$1.0b	0%	0.43%
1.53%	Citigroup Inc.,Banking and Securities Investments	24,932,063	HK$1.0b	0%	0.11%
1.48%	Bosera Asset Management Co., Ltd.	24,023,500	HK$968.1m	0%	0.69%
1.05%	FMR LLC	17,081,839	HK$688.4m	-19%	0.01%
0.92%	Norges Bank Investment Management	14,999,175	HK$604.5m	0%	0.01%
0.88%	Lav Advanced Management Company Limited	14,276,500	HK$575.3m	0%	85.12%
0.62%	China Asset Management Co. Ltd.	10,105,844	HK$407.3m	4.31%	0.08%
0.62%	Schroder Investment Management Limited	10,080,000	HK$406.2m	16.1%	0.03%
0.56%	RBC Global Asset Management Inc.	9,115,794	HK$367.4m	0%	0.03%
0.54%	Schroder Investment Management North America Inc.	8,744,500	HK$352.4m	16.1%	0.15%
0.53%	Polar Capital Holdings Plc	8,551,503	HK$344.6m	0%	0.18%
0.49%	Invesco Ltd.	8,029,000	HK$323.6m	-1.98%	0.01%
0.45%	LAV Investment Adviser Limited	7,345,000	HK$296.0m	0%	no data
0.43%	Penghua Fund Management Co., Ltd.	7,006,500	HK$282.4m	0%	0.25%